Navigation Links
N30 Pharma Announces License Agreement With NitroMed, Inc.
Date:10/29/2007

BOULDER, Colo., Oct. 29 /PRNewswire/ - N30 Pharma (N30), a biopharmaceutical company focused on the discovery, development, and commercialization of respiratory drugs that target endogenous s-nitrosothiols, today announced a licensing agreement with NitroMed Inc. (Nasdaq: NTMD) covering the respiratory use of a s-nitrosothiol drug candidate. Financial terms of the deal were not disclosed.

"I am extremely pleased to announce this agreement. NitroMed is a leader in exploring the medical utility of Nitric Oxide and s-nitrosothiol therapies, and has foundational intellectual property in the area," commented Charles Scoggin, M.D., Chairman of N30 Pharma.

N30 Pharma is developing s-nitrosothiol therapies for critical unmet needs in important respiratory diseases such as cystic fibrosis (CF), asthma, and chronic obstructive pulmonary disease (COPD). S-nitrosothiols are endogenous molecules that store and transduce nitric oxide, and are critical modulators of airway and vascular smooth muscle tone, as well as having other effects. N30 is a privately held company headquartered in Boulder, Colorado.


'/>"/>
SOURCE N30 Pharma
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... generated a new star-shaped molecule made up of interlocking rings, ... , Known as a ,Star of David, molecule, ... quarter of a century and the team,s findings are published ... of two molecular triangles, entwined about each other three times ... each triangle is 114 atoms in length around the perimeter. ...
(Date:9/22/2014)... NEW YORK , Sept. 22, 2014 ... US demand for specialty biocides is forecast to ... 2018. In volume terms, demand is projected to increase ... the same period. A strong rebound in construction expenditures ... and paint and coatings markets, while growth in consumer ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Invisible ... diagnostics for the food and beverage industries, announced ... be distributed under a non-exclusive agreement by Enartis, ... services. , Enartis, an Esseco Group company headquartered ... winemakers in California and other global markets for ...
(Date:9/22/2014)... The US markets on Friday, September 19, ... Jones Industrial Average finished at 17,279.74, up 0.08% and ... S&P 500 finished the session 0.05% lower at 2,010.40. ... finished on a positive note. The S&P 500 Health ... 0.10%, with the index gaining 6.95% in the previous ...
Breaking Biology Technology:US Biocides Market 2US Biocides Market 3Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally 2Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally 3Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 2Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 3Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 4Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 5
... this time (actually it was April rather than May), we ... broke all the meeting records: total attendance, foreign attendance, total ... it, it was broken. But even new records are made ... about? Well, the BIO Annual International Convention , being ...
... on multiple flanks. Google , the Internet utility and search-engine ... 2007, according to Hitwise , is drawing out entrepreneurs and ... slay the giant. One intriguing possibility is evident in the buzz ... about a merger or other sharing of capabilities, according to the ...
... Merge Technologies reported a net loss of $10.1 million, or ... double the net loss of $4.9 million, or $0.15 per share, ... loss was well below the $27.0 million, or $0.80 per share ... continuing difficulties for a company that is trying to emerge from ...
Cached Biology Technology:Olympics of biotechnology has international flavor 2Olympics of biotechnology has international flavor 3Olympics of biotechnology has international flavor 4Olympics of biotechnology has international flavor 5Outflanking the Google, Yahoo, MSN juggernaut 2Outflanking the Google, Yahoo, MSN juggernaut 3Outflanking the Google, Yahoo, MSN juggernaut 4Outflanking the Google, Yahoo, MSN juggernaut 5Outflanking the Google, Yahoo, MSN juggernaut 6
(Date:9/22/2014)... may be at greater risk for stress-related diseases ... according to a new study by Brandeis University. ... trigger biological responses similar to the effects of ... is an important part of our body,s healing ... life-threatening diseases. , In a recently published ...
(Date:9/22/2014)... 2014 NXT-ID, Inc. (NASDAQ: NXTD ... mobile commerce market, issues the following corporate shareholder update ... Letter from the CEO : ... funding and joined the NASDAQ to support ramping of ... biometric and authentication products and services. This strategic achievement positions ...
(Date:9/21/2014)... Assembly events focussed on ways to save and improve ... Canada, funded by the Government of Canada, today announced ... address this challenge. , The novel approaches include: , ... in garment factories to express, pasteurize and store breast ... to child illnesses, and lowering baby formula expense , ...
Breaking Biology News(10 mins):Obesity and stress pack a double hit for health 2NXT-ID Issues Shareholder Corporate Update 2NXT-ID Issues Shareholder Corporate Update 3NXT-ID Issues Shareholder Corporate Update 4Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 2Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 3Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 4Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 5Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 6Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 7Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 8Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 9Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 10Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 11Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 12Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 13Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 14Canada funds 22 innovative projects to help save 'Every Woman, Every Child' 15
... WEST LAFAYETTE, Ind. - Fast-food restaurants can supersize French fries ... supersize a type of apple. Peter Hirst, a Purdue ... some Gala apple trees causes some apples to grow much ... in the current issue of the Journal of Experimental ...
... decrease viral infection rates among phytoplankton and enhance the ... carbon is transferred from the atmosphere to the deep ... findings, published in the Journal of Theoretical Biology ... tackling global warming. Tiny free-floating algae called phytoplankton ...
... to treat rheumatoid arthritis also reduces the damage a stroke ... findings from a clinical trial of stroke patients. The results ... the drug anakinra,s use as an effective therapy for victims ... her team,s latest research into both the causes of brain ...
Cached Biology News:Apples grow larger when cells don't divide, study shows 2Nutrients, viruses and the biological carbon pump 2New hope for victims of stroke 2
MHC. Sections include: the isolation and functional properties of antigen-presenting cells analysis of MHC class II endocytosis and peptide turnover analysis of signalling via MHC class II molecu...
Supplemental reagent for annexin V assay....
Large-fragment, single-stranded carrier DNA of the highest quality, perfectly suited for all types of yeast transformation....
Qa-1 (L-12)...
Biology Products: